Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database

BACKGROUND: Incretin-based drugs are important in the treatment of type 2 diabetes. However, among the incretin-based drugs, glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have been reported to cause gastroesophageal reflux disease (GERD)-like symptoms making it difficult to continue treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguchi, Yoshihiro, Katsuno, Hayato, Ueno, Anri, Otsubo, Manami, Yoshida, Aki, Kanematsu, Yuta, Sugita, Ikuto, Esaki, Hiroki, Tachi, Tomoya, Tsuchiya, Teruo, Teramachi, Hitomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004661/
https://www.ncbi.nlm.nih.gov/pubmed/29946474
http://dx.doi.org/10.1186/s40780-018-0109-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004661/
https://www.ncbi.nlm.nih.gov/pubmed/29946474
http://dx.doi.org/10.1186/s40780-018-0109-z

Ejemplares similares